DOTSENKO; Irina

Patent Applications and Registrations

Patent applications and USPTO patent grants for DOTSENKO; Irina.The latest application filed is for "compounds useful for treating gastrointestinal tract disorders".

Company Profile

8.6.9

DOTSENKO; Irina - Fremont CA
Dotsenko; Irina - San Jose CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds Useful For Treating Gastrointestinal Tract Disorders App 20220306610 - DRAGOLI; Dean ; et al.	2022-09-29
Compounds useful for treating gastrointestinal tract disorders Grant 11,242,337 - Dragoli , et al. February 8, 2	2022-02-08
Inhibitors of NHE-mediated antiport Grant 11,147,884 - Dotsenko , et al. October 19, 2	2021-10-19
Pegylated carfilzomib compounds Grant 11,077,198 - Luehr , et al. August 3, 2	2021-08-03
Pegylated Carfilzomib Compounds App 20200376131 - LUEHR; Gary ; et al.	2020-12-03
Pegylated carfilzomib compounds Grant 10,675,353 - Luehr , et al.	2020-06-09
Pegylated Carfilzomib Compounds App 20200069808 - LUEHR; Gary ; et al.	2020-03-05
Pegylated carfilzomib compounds Grant 10,517,954 - Luehr , et al. Dec	2019-12-31
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt App 20190374533 - CHARMOT; Dominique ; et al.	2019-12-12
Inhibitors Of Nhe-mediated Antiport App 20190374649 - DOTSENKO; Irina ; et al.	2019-12-12
Compounds Useful For Treating Gastrointestinal Tract Disorders App 20190359599 - DRAGOLI; Dean ; et al.	2019-11-28
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Grant 10,376,481 - Bell , et al. A	2019-08-13
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders App 20170368004 - BELL; Noah ; et al.	2017-12-28
Pegylated Carfilzomib Compounds App 20170340746 - LUEHR; Gary ; et al.	2017-11-30
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders App 20170340623 - CHARMOT; Dominique ; et al.	2017-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.